Teladoc Health (NYSE:TDOC) Insider Sells $17,406.76 in Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Fernando Rodrigues sold 2,324 shares of the firm’s stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $17,406.76. Following the completion of the transaction, the insider directly owned 4,209 shares of the company’s stock, valued at approximately $31,525.41. This trade represents a 35.57% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.

Teladoc Health Price Performance

TDOC traded up $0.03 during trading on Wednesday, hitting $7.53. The company’s stock had a trading volume of 4,719,190 shares, compared to its average volume of 5,787,774. The firm’s 50 day moving average price is $8.02 and its two-hundred day moving average price is $7.76. The stock has a market capitalization of $1.34 billion, a price-to-earnings ratio of -5.88 and a beta of 2.04. The company has a quick ratio of 2.60, a current ratio of 2.70 and a debt-to-equity ratio of 0.71. Teladoc Health, Inc. has a 12 month low of $6.35 and a 12 month high of $15.21.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 29th. The health services provider reported ($0.21) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.26) by $0.05. The business had revenue of $626.44 million for the quarter, compared to analyst estimates of $625.66 million. Teladoc Health had a negative return on equity of 10.59% and a negative net margin of 8.84%.The firm’s revenue for the quarter was down 2.2% compared to the same quarter last year. During the same quarter in the prior year, the firm posted ($0.19) earnings per share. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. Sell-side analysts forecast that Teladoc Health, Inc. will post -1.16 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Teladoc Health

Several hedge funds have recently added to or reduced their stakes in TDOC. National Bank of Canada FI increased its holdings in shares of Teladoc Health by 79.4% in the first quarter. National Bank of Canada FI now owns 3,571 shares of the health services provider’s stock valued at $28,000 after purchasing an additional 1,581 shares during the last quarter. IFP Advisors Inc grew its stake in Teladoc Health by 412.1% in the 3rd quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after buying an additional 3,210 shares during the last quarter. SVB Wealth LLC bought a new position in Teladoc Health in the 1st quarter valued at about $37,000. Aster Capital Management DIFC Ltd lifted its position in Teladoc Health by 101.1% during the third quarter. Aster Capital Management DIFC Ltd now owns 4,823 shares of the health services provider’s stock worth $37,000 after acquiring an additional 2,425 shares during the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of Teladoc Health during the first quarter worth approximately $50,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on TDOC shares. Zacks Research lowered shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. BMO Capital Markets assumed coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price target on the stock. Bank of America decreased their price objective on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a report on Tuesday, November 25th. Citigroup upped their target price on Teladoc Health from $9.50 to $10.50 and gave the stock a “neutral” rating in a report on Tuesday, October 21st. Finally, Weiss Ratings restated a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday. Five investment analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average price target of $9.68.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.